Medical sector’s Minerva Neurosciences’s (NASDAQ:NERV) Buy rating Reiterated by HC Wainwright

Minerva Neurosciences has a twelve month low $1.81 of and a twelve month high of $15.22. Shares of Minerva Neurosciences traded down -$0.21 on …

Link to Full Article: Read Here